See more of what matters

5 Pages

Da Volterra wanted to maximize the power of their clinical trial for scenarios with a smaller treatment effect, and were contemplating a Sample Size Re-estimation design. Unfortunately, with a strict enrollment limit of 1,100 patients, this particular study design produced only marginal gains in power over the fixed sample size design.

Join for free to read

Report WHAT MATTERS TO TODAY'S CONSUMER

Case Study ‘Zero consumers’: What they want and why it matters

White Paper More affordable care matters

White Paper Dispute management matters

More from StatXact

Case Study Are You Harnessing the Power of Your Clinical Data?

Case Study Re-imagining Clinical Trials

Case Study REIMAGINING CLINICAL TRIAL DESIGN

Case Study Enhanced Access to Innovative Bayesian Clinical Trial Designs

Case Study

See more of what matters

See more of what matters

You Might Also Like

More from StatXact